ASSESSMENT OF THE DIRECT ACTING ANTIVIRALS USED TO TREAT THE HEPATITIS C VIRUS GENOTYPE 1 INFECTION IN A TERTIARY HOSPITAL
4CPS-085
ASSESSMENT OF THE DIRECT-ACTING ANTIVIRALS USED TO TREAT THE HEPATITIS C VIRUS GENOTYPE 4 INFECTION IN A TERTIARY HOSPITAL
4CPS-084
IDENTIFICATION OF PATIENT CANDIDATES TO SWITCH FROM TENOFOVIR/EMTRICITABINE TO ABACAVIR/ LAMIVUDINE ANTIRETROVIRAL THERAPY: ECONOMIC SAVING
4CPS-079
FACTORS IMPLICATED IN LIPID PROFILE CONTROL AMONG HIV-INFECTED PATIENTS IN TREATMENT WITH PROTEASE INHIBITORS
4CPS-078
IDENTIFICATION OF CANDIDATE DUAL/ MONOTHERAPY PATIENTS IN TREATMENT WITH PROTEASE INHIBITORS: ECONOMIC SAVINGS
4CPS-074
IMPACT OF ANTIBIOTIC PROPHYLAXIS GUIDELINES IN OBSTETRIC AND GYNAECOLOGY SURGERY: A RETROSPECTIVE MULTI-CENTRE STUDY
4CPS-073
EVALUATION OF CARBAPENAEMIC TREATMENTS AND ANTIMICROBIAL STEWARDSHIP
4CPS-072
ARE WE PROPERLY DOSING ANTIBIOTICS IN ENTEROCOCCUS FAECIUM BACTERAEMIA?
4CPS-071
THERAPEUTIC DRUG MONITORING AND SAFETY OF HIGH-DOSE AMIKACIN IN CRITICALLY ILL PATIENTS
4CPS-068
SUB-THERAPEUTIC PLASMA LEVELS OF LINEZOLID IN THE ICU: USUAL OR UNUSUAL IN THIS SETTING?
4CPS-065
ADEQUACY OF VANCOMYCINE DOSAGE IN THE INTENSIVE CARE UNIT OF A UNIVERSITY HOSPITAL
4CPS-062
PHARMACIST INTERVENTION FOR THE IMPROVEMENT IN THE USE OF ANTIBIOTICS IN SURGERY SERVICE
4CPS-060
PHARMACEUTICAL ROLE IN AN ANTIMICROBIAL STEWARDSHIP PROGRAMME
4CPS-054
EARLY LEVELS OF VANCOMYCIN IN INTENSIVE CARE UNIT (ICU) PROTOCOL DEPENDING ON ICU PATIENTS’ CHARACTERISTICS
4CPS-050
COMPARATIVE STUDY BETWEEN THREE SEQUENTIAL SEMESTERS TO EVALUATE THE IMPLEMENTATION OF ANTIBIOTICS’ STEWARDSHIP PROGRAMME IN INTENSIVE CARE UNIT OF A 500-BED GENERAL HOSPITAL
